Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gamida Cell Ltd. - Ordinary Shares (NQ:GMDA)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Gamida Cell Ltd. - Ordinary Shares

< Previous 1 2 3 Next >
Gamida Cell Initiates Rolling Submission of Biologics License Application for Omidubicel
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Ltd. (NASDAQ:GMDA) Investor Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 01/27/2022 -- Certain directors of Gamida Cell Ltd are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer
Palm Beach, FL – January 20, 2022 – FinancialNewsMedia.com News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to... 
Via FinancialNewsMedia
Topics Death
Exposures Death
Gamida Cell Provides Update on Omidubicel BLA Submission
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Data to be Presented at 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Ltd. (NASDAQ:GMDA) Shareholder Alert: Investigation over Possible Violations of Securities Laws
San Diego, CA -- (SBWIRE) -- 12/13/2021 -- Gamida Cell Ltd is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Exposures Product Safety
Gamida Cell Presents Two-Year Survival Data for GDA-201 and Resource Utilization Analysis for Omidubicel at 63rd ASH Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Presents New Omidubicel Data at 63rd ASH Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Reports Third Quarter 2021 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Provides Update on Pre-BLA Meeting With FDA for Omidubicel
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Presents New Data on Nicotinamide-Enabled NK Cell Therapy at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces the Date of Its Third Quarter 2021 Financial Results and Webcast
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Data to Be Presented at 63rd ASH Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Presents Data on its NAM-Enabled NK Cell Therapies at Protein & Antibody Engineering Summit (PEGS) Europe
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Host Virtual Event Highlighting GDA-201 and NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in September
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Reports Second Quarter 2021 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces the Date of Its Second Quarter 2021 Financial Results and Webcast
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present at the BTIG Virtual Biotechnology Conference
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Publication in Blood, the Journal of the American Society of Hematology, of the First Pivotal Trial to Evaluate a Cell Therapy (Omidubicel) for Patients with Blood Cancer who Require an Allogeneic Stem Cell Transplant
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in June
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell to Present at the RBC Capital Markets Global Healthcare Conference
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update
From Gamida Cell Ltd.
Via Business Wire
Gamida Cell Announces the Date of Its First Quarter 2021 Financial Results and Webcast
From Gamida Cell Ltd.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.